Daniel Guthy

Affiliations

Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.

Réseau de co-auteurs

Mylene Lanter 2 collaborations

Alan Zhang 1 collaboration

Katherine Seiss 1 collaboration

Laurent Laborde 1 collaboration

Sebastian Palacio-Ramirez 1 collaboration

Julien Lorber 1 collaboration

Anna Vulpetti 1 collaboration

Luca Arista 1 collaboration

Thomas Zoller 1 collaboration

Thomas Radimerski 1 collaboration

Claudio Thoma 1 collaboration

Christina Hebach 1 collaboration

William R Tschantz 1 collaboration

Alexei Karpov 1 collaboration

Gregory J Hollingworth 1 collaboration

Joseph A D'Alessio 1 collaboration

Stephane Ferretti 1 collaboration

Matthew T Burger 1 collaboration

Frédéric Stauffer 1 collaboration

Andreas Weiss 1 collaboration

Clemens Scheufler 1 collaboration

Henrik Möbitz 1 collaboration

Christian Ragot 1 collaboration

Kim S Beyer 1 collaboration

Keith Calkins 1 collaboration

Michael Kiffe 1 collaboration

Bernard Van Eerdenbrugh 1 collaboration

Ralph Tiedt 1 collaboration

Christoph Gaul 1 collaboration

Anke Bill 1 collaboration

Sheryll Espinola 1 collaboration

Jacob R Haling 1 collaboration

Min Lu 1 collaboration

Anthony Marelli 1 collaboration

Angelica Mendiola 1 collaboration

Loren Miraglia 1 collaboration

Brandon L Taylor 1 collaboration

Leonardo Vargas 1 collaboration

Anthony P Orth 1 collaboration

Frederick J King 1 collaboration

Daniel Guthy

Affiliations

Publications (3)

Design, Synthesis, and In Vitro and In Vivo Evaluation of Cereblon Binding Bruton's Tyrosine Kinase (BTK) Degrader CD79b Targeted Antibody-Drug Conjugates.

New Potent DOT1L Inhibitors for

EndoBind detects endogenous protein-protein interactions in real time.

Réseau de co-auteurs